41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A 1–A 2A Receptor Heteromers

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The functional role of heteromers of G-protein-coupled receptors is a matter of debate. In the present study, we demonstrate that heteromerization of adenosine A 1 receptors (A 1Rs) and A 2A receptors (A 2ARs) allows adenosine to exert a fine-tuning modulation of glutamatergic neurotransmission. By means of coimmunoprecipitation, bioluminescence and time-resolved fluorescence resonance energy transfer techniques, we showed the existence of A 1R–A 2AR heteromers in the cell surface of cotransfected cells. Immunogold detection and coimmunoprecipitation experiments indicated that A 1R and A 2AR are colocalized in the same striatal glutamatergic nerve terminals. Radioligand-binding experiments in cotransfected cells and rat striatum showed that a main biochemical characteristic of the A 1R–A 2AR heteromer is the ability of A 2AR activation to reduce the affinity of the A 1R for agonists. This provides a switch mechanism by which low and high concentrations of adenosine inhibit and stimulate, respectively, glutamate release. Furthermore, it is also shown that A 1R–A 2AR heteromers constitute a unique target for caffeine and that chronic caffeine treatment leads to modifications in the function of the A 1R–A 2AR heteromer that could underlie the strong tolerance to the psychomotor effects of caffeine.

          Related collections

          Author and article information

          Journal
          J Neurosci
          J. Neurosci
          jneuro
          The Journal of Neuroscience
          Society for Neuroscience
          0270-6474
          1529-2401
          15 February 2006
          : 26
          : 7
          : 2080-2087
          Affiliations
          1Department of Biochemistry and Molecular Biology, University of Barcelona, 08028 Barcelona, Spain, 2Centre for Neuroscience of Coimbra, Institute of Biochemistry, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal, 3Facultad de Medicina and Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02006 Albacete, Spain, 4Target Validation, Laboratoris Dr. Esteve, Parc Científic de Barcelona, 08028 Barcelona, Spain, 5Behavioral Neuroscience Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, and 6Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom
          Author notes
          Correspondence should be addressed to Sergi Ferré, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224. Email: sferre@ 123456intra.nida.nih.gov
          Article
          PMC6674939 PMC6674939 6674939 zns2080
          10.1523/JNEUROSCI.3574-05.2006
          6674939
          16481441
          d3854098-a5f0-4e2d-8f37-d386bbeae5b4
          Copyright © 2006 Society for Neuroscience 0270-6474/06/262080-08$15.00/0
          History
          : 10 January 2006
          : 23 August 2005
          : 9 January 2005
          Categories
          Articles
          Cellular/Molecular
          Custom metadata
          2080
          research-article

          heteromeric receptors,adenosine A1 receptor,adenosine A2A receptor,glutamate,striatum,caffeine

          Comments

          Comment on this article